Source: Novotech
Novotech is a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and small- to mid-sized pharmaceutical companies seeking to advance drug development. With deep therapeutic and regulatory expertise and an expansive global footprint across the Asia-Pacific region, North America, and Europe, Novotech offers clients an accelerated path to bring life-changing therapies to market. This presentation explores the evolving landscape of early-phase oncology clinical trials, offering key market trends and strategic insights to empower clinical trial operations teams in optimizing study design, site selection, and patient recruitment.